Herbas VPB

Print
EN | LT
LT - ORAL DOSAGE FORM OF APOPTOSIS SIGNAL-REGULATING KINASE INHIBITORS
EN - ORAL DOSAGE FORM OF APOPTOSIS SIGNAL-REGULATING KINASE INHIBITORS

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C07D 401/12
C07D 401/14
C07D 407/14
C07D 413/14
C07D 471/04
C07D 491/048
A61K 31/437
A61K 31/4439
A61K 31/444
A61K 31/497
A61K 31/506
A61P 9/00
A61P 25/28
A61P 29/00
A61P 37/00
A61K 31/585
A61K 31/5377
A61K 31/496
A61K 31/4709
A61K 45/06
European patent
(11) Number of the document 3363797
(13) Kind of document T
(96) European patent application number 17208659.7
Date of filing the European patent application 2010-07-12
(97) Date of publication of the European application 2018-08-22
(45) Date of publication and mention of the grant of the patent 2020-12-02
(46) Date of publication of the claims translation
Priority applications
(30) Number Date Country code
225076 P 2009-07-13 US
225079 P 2009-07-13 US
289263 P 2009-12-22 US
Inventors
(72)
CORKEY, Britton, US
GRAUPE, Michael, US
KOCH, Keith, US
MELVIN, Lawrence S., US
NOTTE, Gregory, US
Grantee
(73) Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, CA 94404, US
Title
(54) ORAL DOSAGE FORM OF APOPTOSIS SIGNAL-REGULATING KINASE INHIBITORS
  ORAL DOSAGE FORM OF APOPTOSIS SIGNAL-REGULATING KINASE INHIBITORS